Literature DB >> 4155971

Effects of tiprenolol, practolol and propranolol on experimental ventricular tachyarrhythmias.

J D Allen, R G Shanks.   

Abstract

1 Low doses of tiprenolol (0.01-0.02 mg/kg) and propranolol (0.05 mg/kg) abolished the ventricular arrhythmias produced by the intravenous injection of adrenaline in anaesthetized dogs respired with halothane.2 Larger doses of tiprenolol (2.0-4.0 mg/kg) restored sinus rhythm in four of five dogs with ventricular tachycardia produced by toxic doses of ouabain. Propranolol (2.0-4.0 mg/kg) had the same effect in each of four dogs.3 Both tiprenolol (4.0-8.0 mg/kg) and propranolol (4.0 mg/kg) increased the frequency of sinus beats and reduced the ventricular rate in dogs with ventricular tachycardia 20-44 h after ligation of a coronary artery.4 Practolol (0.5-16.0 mg/kg) did not reduce the ventricular rate or increase the frequency of sinus beats in dogs with ventricular tachycardia after ligation of a coronary artery.5 In dogs with ouabain-induced ventricular tachycardia mean arterial pressure was reduced after the administration of tiprenolol (0.5-8.0 mg/kg) or propranolol (4.0-8.0 mg/kg). Depression of sinus and atrioventricular nodal function, and of intraventricular conduction developed in some of the dogs given tiprenolol (4-8 mg/kg) or propranolol (8.0 mg/kg).6 The administration of tiprenolol (1.0-8.0 mg/kg) or propranolol (4.0-8.0 mg/kg) depressed the arterial pressure and caused the deaths of some dogs in which a coronary artery had been ligated. Such deaths did not occur in the group which had been given toxic doses of ouabain.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4155971      PMCID: PMC1776753          DOI: 10.1111/j.1476-5381.1974.tb09645.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  17 in total

1.  Unwanted effects of propranolol.

Authors:  S A Stephen
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

2.  Antiarrhythmic actions of 4-(2-hydroxy-3-isopropylaminopropoxy)-acetanilide (ICI 50,172) in the dog heart-lung preparation.

Authors:  A R Laddu; P Somani
Journal:  J Pharmacol Exp Ther       Date:  1969-11       Impact factor: 4.030

3.  Selective blockade of adrenoceptive beta receptors in the heart.

Authors:  D Dunlop; R G Shanks
Journal:  Br J Pharmacol Chemother       Date:  1968-01

4.  The antiarrhythmic properties of ICI 46037, a quaternary analog of propranolol.

Authors:  B R Lucchesi; T Iwami
Journal:  J Pharmacol Exp Ther       Date:  1968-07       Impact factor: 4.030

5.  Controlled trial of propranolol in thyrotoxicosis.

Authors:  R G Shanks; D R Hadden; D C Lowe; D G McDevitt; D A Montgomery
Journal:  Lancet       Date:  1969-05-17       Impact factor: 79.321

6.  Practolol in the treatment of cardiac dysrhythmias due to acute myocardial infarction.

Authors:  D E Jewitt; C J Mercer; J P Shillingford
Journal:  Lancet       Date:  1969-08-02       Impact factor: 79.321

7.  Propranolol in patients with angina pectoris.

Authors:  R E Gianelly; R H Goldman; B Treister; D C Harrison
Journal:  Ann Intern Med       Date:  1967-12       Impact factor: 25.391

Review 8.  The use of beta-adrenergic receptor blocking drugs in dysrhythmias.

Authors:  D Gibson; E Sowton
Journal:  Prog Cardiovasc Dis       Date:  1969-07       Impact factor: 8.194

Review 9.  Beta-adrenergic receptor blocking drugs. Mechanisms of action and clinical applications.

Authors:  S E Epstein; E Braunwald
Journal:  N Engl J Med       Date:  1966-11-24       Impact factor: 91.245

10.  Treatment of hypertension with propranolol.

Authors:  B N Prichard; P M Gillam
Journal:  Br Med J       Date:  1969-01-04
View more
  2 in total

1.  Effects of the myocardial-selective alpha 1-adrenoceptor antagonist UK-52046 and atenolol, alone and in combination, on experimental cardiac arrhythmias in dogs.

Authors:  A G Uprichard; D W Harron; R Wilson; R G Shanks
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

2.  Proceedings of the British Pharmacological Society. 16--18th December, 1980.

Authors: 
Journal:  Br J Pharmacol       Date:  1981-05       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.